feed,title,long_url,short_url
Benzinga,NRx Pharma Says I-SPY Study Of Inhaled Zyesami In Critical COVID-19 Stopped,https://benzinga.com/general/biotech/22/03/26399480/nrx-pharma-says-i-spy-study-of-inhaled-zyesami-in-critical-covid-19-stopped,https://bit.ly/3wQsWld
Benzinga,InflaRx Shares Plunge After Disappointing Results On Vilobelimab In Critically Ill COVID-19 Patients,https://benzinga.com/general/biotech/22/03/26400569/inflarx-shares-plunge-after-disappointing-results-on-vilobelimab-in-critically-ill-covid-19-patie,https://bit.ly/372J2Nw
Benzinga,Supply Chain Challenges To Hit Masimo's Q1 FY22 Sales,https://benzinga.com/news/earnings/22/03/26396684/supply-chain-challenges-to-hit-masimos-q1-fy22-sales,https://bit.ly/3qTiVQl
